XML 47 R37.htm IDEA: XBRL DOCUMENT
v3.25.2

Investment in Associates and Joint Ventures (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Investment in Associates and Investments in Investees [Abstract] |
Schedule of Fair Value of the Investment | The table below summarizes the fair value of the investment in MitoCareX:
Balance at January 1, 2022 |  | $ | - |
Investment date March 31, 2022 |  |  | 700 |
Equity losses from investment in MitoCareX |  |  | (109 | )
Balance at December 31, 2022 |  | $ | 591 |
Investment following achievement of first milestone |  |  | 400 |
Equity losses from investment in MitoCareX |  |  | (210 | )
Balance at December 31, 2023 |  | $ | 781 |
Investment following achievement of second milestone |  | $ | 600 |
Equity losses from investment in MitoCareX |  |  | (429 | )
Balance at December 31, 2024 |  | $ | 952 |

X
- Definition The disclosure of investments accounted for using the equity method. [Refer: Investments accounted for using equity method] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 10 -Subparagraph e -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_10_e&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | sprcy_InvestmentinAssociatesandJointVenturesTablesLineItems
Namespace Prefix: | sprcy_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration